Camp4 Therapeutics Corporation
CAMP
$4.44
$0.040.80%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 37.48% | 271.84% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 37.48% | 271.84% | |||
| Cost of Revenue | 6.47% | 21.57% | |||
| Gross Profit | -1.94% | -10.70% | |||
| SG&A Expenses | 3.26% | -11.79% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.53% | 9.46% | |||
| Operating Income | -2.36% | -2.31% | |||
| Income Before Tax | -82.91% | 54.50% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -82.91% | 54.50% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -82.91% | 54.50% | |||
| EBIT | -2.36% | -2.31% | |||
| EBITDA | -2.50% | -1.19% | |||
| EPS Basic | -82.88% | 57.69% | |||
| Normalized Basic EPS | -82.91% | 57.69% | |||
| EPS Diluted | -82.88% | 57.69% | |||
| Normalized Diluted EPS | -82.91% | 57.69% | |||
| Average Basic Shares Outstanding | 0.01% | 7.55% | |||
| Average Diluted Shares Outstanding | 0.01% | 7.55% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||